MECHANISMS OF ACTIONS OF ALCOHOL AND OMEGA 3-FATTY ACIDS
MECHANISMS OF ACTIONS OF ALCOHOL AND OMEGA 3-FATTY ACIDS
批准号:
6463551
负责人:
RAJ M LAKSHMAN
金额:
$5.8万
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-07-01 至 2002-03-31
关键词:
alcoholism /alcohol abuse apolipoprotein E blood lipoprotein metabolism cholesterol ethanol fatty liver genetic regulatory element glycosylation high density lipoproteins human tissue immunochemistry laboratory rat lipid metabolism lipid transport liver metabolism messenger RNA omega 3 fatty acid phospholipids protein structure function protein transport sialyltransferases sphingomyelins tissue /cell culture toxicology transcription factor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (Adapted from the applicant's abstract): The major hypotheses of
this competing continuation application are: Ethanol exposure down-regulates
alpha-2,6-sialyltransferase (2,6-ST) at the molecular level leading to
defective glycosylation of apolipoprotein E (ApoE) and its association with
HDL. Ethanol also affects sphingomyelin (SPM) and other phospholipids (PL) of
HDL. These defects lead to impaired reverse cholesterol transport (RCT) that
are reversed by low dietary omega 3-faty acids (omega 3FA). This laboratory has
the following published (10 publication & 1 review) and preliminary data in
support of the above hypotheses: 1. Ethanol impaired sialylation of both
transferring (Tf) and ApoE by down-regulating 2,6-ST and its mRNA. 2. Both
2,6-ST-mRNA and GAPDH mRNA levels seemed to be intact in two autopsy liver
samples from non-alcoholic controls. 3. Ethanol at 50 and 100mM decreased ST
mRNA in human HepG2 cells stably expressing Cyp2E (Cyp2E cells) and high
alcohol dehydrogenase (ADH cells), but not in Wild type. 4. However,
acetaldehyde (Ach) at 50muM concentration decreased 2,6-ST mRNA even in Wilde
type. 5. Ethanol destabilized liver 2,6-STmRNA, presumably via cis and trans-
acting factors. 6. Desialylated ApoE had low affinity for HDL resulting in its
impaired RCT function in both human and rat. 7. HDLs from both chronic
ethanol-fed rats and human alcoholics showed defective RCT. 8. Very low dietary
omega 3FA restored ethanol-mediated inhibition of RCT capacity of HDL. 9. Both
20:5 and 22:6 omega 3FA contents of HDL increased 4-4.7-fold in omega 3FA-fed
group compared to the control group. 10. Sphingomyelin (SPM) content of HDL was
decreased in ethanol group with concomitant inhibition of RCT. 11. HDLs from
chronic human alcoholics also had lower HDL SPM compared to non-drinkers. 12.
HDL devoid of SPM showed impaired RCT function. Therefore, the following
specific aims are proposed to test hypotheses to understand the mechanisms of
actions of alcohol and omega 3FA: Glycosylation: Specific Aim 1: Are protein
factors involved in the ethanol-mediated destabilization of liver 2,6-ST mRNA?
How does ethanol affect the distribution of 2,6-ST protein & its mRNA? Do
livers from human alcoholics also exhibit decreased 2,6-ST protein & its mRNA?
Specific Aim 2: Can the effects of ethanol in vivo be mimicked in human liver
cell systems? Is active metabolism of ethanol a prerequisite for its effects in
these cell systems? What are the cis and trans factors responsible for
destabilizing 2,6-ST mRNA? Is Ach responsible for these effects at clinically
relevant levels? Functional Consequences: Specific Aim 3: How do omega 3 FA
alter ethanol-mediated defects in the RCT function of HDL? Specific Aim 4: Does
ethanol affect the HDL SPM and other PL? Do human alcoholics have altered SPM
and other PL levels in their HDL? Does ethanol-induced loss of SPM and other
PL? Do human alcoholics have altered SPM and other PL levels in their HDL? Does
ethanol-induced loss of SPM and other PL from HDL affect its RCT function? The
laboratory will accomplish these in human and animal systems using molecular
biology, immunochemical and biochemical approaches.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ANTI INFLAMMATORY AND ANTIFIBROTIC ACTIONS OF THYMOSIN BETA 4 IN ALD
-
批准号:8854003
-
项目类别:
-
资助金额:$17.57万
-
财政年份:2014
-
负责人:RAJ M LAKSHMAN
-
依托单位:
ANTI INFLAMMATORY AND ANTIFIBROTIC ACTIONS OF THYMOSIN BETA 4 IN ALD
-
批准号:8609964
-
项目类别:
-
资助金额:$14.96万
-
财政年份:2014
-
负责人:RAJ M LAKSHMAN
-
依托单位:
Novel Modulators of Alcohol Induced Metabolic and Liver Injury
-
批准号:8724156
-
项目类别:
-
资助金额:$10.6万
-
财政年份:2013
-
负责人:RAJ M LAKSHMAN
-
依托单位:
NOVEL MODULATORS OF ALCOHOL INDUCED METABOLIC AND LIVER INJURY
-
批准号:8307287
-
项目类别:
-
资助金额:$29.93万
-
财政年份:2011
-
负责人:RAJ M LAKSHMAN
-
依托单位:
NOVEL MODULATORS OF ALCOHOL INDUCED METABOLIC AND LIVER INJURY
-
批准号:8504896
-
项目类别:
-
资助金额:$27.83万
-
财政年份:2011
-
负责人:RAJ M LAKSHMAN
-
依托单位:
NOVEL MODULATORS OF ALCOHOL INDUCED METABOLIC AND LIVER INJURY
-
批准号:8702054
-
项目类别:
-
资助金额:$39.31万
-
财政年份:2011
-
负责人:RAJ M LAKSHMAN
-
依托单位:
NOVEL MODULATORS OF ALCOHOL INDUCED METABOLIC AND LIVER INJURY
-
批准号:8203160
-
项目类别:
-
资助金额:$26.78万
-
财政年份:2011
-
负责人:RAJ M LAKSHMAN
-
依托单位:
NOVEL MODULATORS OF ALCOHOL INDUCED METABOLIC AND LIVER INJURY
-
批准号:8460995
-
项目类别:
-
资助金额:$3.15万
-
财政年份:2011
-
负责人:RAJ M LAKSHMAN
-
依托单位:
NOVEL MODULATORS OF ALCOHOL INDUCED METABOLIC AND LIVER INJURY
-
批准号:8900880
-
项目类别:
-
资助金额:$45.4万
-
财政年份:2011
-
负责人:RAJ M LAKSHMAN
-
依托单位:
BRAIN SOCS3 AND PTP1B-ADIPOSE LEPTIN FEEDBACK AXIS IN ALCOHOLIC HEPATOSTEATOSIS
-
批准号:8144479
-
项目类别:
-
资助金额:$15.14万
-
财政年份:2010
-
负责人:RAJ M LAKSHMAN
-
依托单位:
BRAIN SOCS3 AND PTP1B-ADIPOSE LEPTIN FEEDBACK AXIS IN ALCOHOLIC HEPATOSTEATOSIS
-
批准号:8065693
-
项目类别:
-
资助金额:$18.9万
-
财政年份:2010
-
负责人:RAJ M LAKSHMAN
-
依托单位:
MODULATORS OF ALCOHOLIC LIPIDEMIA & STEATOSIS:KEY ROLE OF SCAVENGER RECEPTOR B I
-
批准号:7926902
-
项目类别:
-
资助金额:$15.75万
-
财政年份:2009
-
负责人:RAJ M LAKSHMAN
-
依托单位:
ACTION OF ALCOHOL/QUERCETIN ON ANTI-ATHEROGENIC FACTOR
-
批准号:7146990
-
项目类别:
-
资助金额:$18.11万
-
财政年份:2006
-
负责人:RAJ M LAKSHMAN
-
依托单位:
ACTION OF ALCOHOL & QUERCETIN ON ANTI-ATHEROGENIC FACTORS & ATHEROGENESIS
-
批准号:7267983
-
项目类别:
-
资助金额:$17.59万
-
财政年份:2006
-
负责人:RAJ M LAKSHMAN
-
依托单位:
Light & Heavy Alcohol, Paraoxonase & Oxidized LDL Status
-
批准号:6542331
-
项目类别:
-
资助金额:$28.35万
-
财政年份:2002
-
负责人:RAJ M LAKSHMAN
-
依托单位:
Light & Heavy Alcohol, Paraoxonase & Oxidized LDL Status
-
批准号:6917377
-
项目类别:
-
资助金额:$6.28万
-
财政年份:2002
-
负责人:RAJ M LAKSHMAN
-
依托单位:
Light & Heavy Alcohol, Paraoxonase & Oxidized LDL Status
-
批准号:6744843
-
项目类别:
-
资助金额:$28.35万
-
财政年份:2002
-
负责人:RAJ M LAKSHMAN
-
依托单位:
Light & Heavy Alcohol, Paraoxonase & Oxidized LDL Status
-
批准号:6890039
-
项目类别:
-
资助金额:$34.82万
-
财政年份:2002
-
负责人:RAJ M LAKSHMAN
-
依托单位:
Light & Heavy Alcohol, Paraoxonase & Oxidized LDL Status
-
批准号:7623633
-
项目类别:
-
资助金额:$3.15万
-
财政年份:2002
-
负责人:RAJ M LAKSHMAN
-
依托单位:
Light & Heavy Alcohol, Paraoxonase & Oxidized LDL Status
-
批准号:7057373
-
项目类别:
-
资助金额:$34.35万
-
财政年份:2002
-
负责人:RAJ M LAKSHMAN
-
依托单位:
海外基金